Latest Governance News

AIMS Property Securities Fund (APW) reported a remarkable financial year ending June 2025, with net income and revenue more than doubling and net tangible assets per unit rising 31.8%. The fund’s conservative, debt-free approach and diversified portfolio helped it outperform the broader market despite ongoing distribution suspensions.

BauMart Holdings Limited has dramatically reduced its net loss to $123,086 for the year ended June 2025, down from $4.68 million the previous year, as it advances strategic initiatives and strengthens its financial position through a rights issue.

Argent BioPharma reported a net loss of A$17.84 million for FY2025, reflecting a strategic pivot towards core drug development and clinical advancement. The company secured key EU approvals and raised significant capital to support its neuro-immune modulatory pipeline.

Singular Health Group reported a $6.38 million loss for FY2025 while securing a pivotal $1.3 million commercial agreement with US-based Provider Network Solutions to deploy its 3DICOM software. The company also completed a major cloud migration of its platform, positioning itself for growth in the US healthcare market.

Synertec Corporation Limited reported an 8% revenue decline to $18.2 million in FY2025 alongside a $7.64 million net loss, yet its Engineering segment showed a strong EBITDA rebound and its Powerhouse renewable technology revenue nearly doubled.

5G Networks Limited (5GN) reported a robust 27% revenue increase in FY25, driven by organic growth and a strategic acquisition of an 89.65% stake in cybersecurity firm AUCyber. The company’s underlying EBITDA turned positive, signaling a financial turnaround despite integration costs.

5G Networks has reported a strong FY25 with an 8% revenue increase and a positive EBITDA turnaround, driven by the strategic acquisition of cyber security firm AUCyber. The company’s expansion into sovereign cloud services signals a new growth chapter.

Finexia Financial Group has restated its FY24 financials due to a material error in expense accruals and reduced the value of its Stayco investment by $4 million following an external valuation review.

Chimeric Therapeutics reported a reduced net loss of $10.43 million for FY2025, driven by cost efficiencies and strategic project reprioritisation, while making significant clinical progress in its CAR T-cell and NK cell therapy programs.

NoviqTech Limited reported a $1.63 million loss for the half-year ending June 2025, while securing key partnerships and raising over $1 million to fuel its sustainability and blockchain innovation.

The Takeovers Panel has declined to intervene in PointsBet’s issuance of over 10 million new shares during a fierce takeover contest, affirming the board’s discretion amid competing bids from betr and MIXI Australia.

My Rewards International Limited reports a 47% revenue drop but narrows losses by 45%, fueled by strategic acquisition and tech innovation. The company advances ASX reinstatement with a capital raise and debt conversion plan.